- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prostate cancer
- Meeting Date: November 2022
- Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 617KB)
- Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 179KB)
Abiraterone and methylprednisolone – November 2022
Abiraterone and Methylprednisolone: Pack containing 120 tablets abiraterone (as acetate) 125 mg and 60 tablets methylprednisolone 4 mg; Yonsa® Mpred™
Last updated
3 March 2023